0% found this document useful (0 votes)
37 views

Multiple Myeloma

Uploaded by

Momo Semo
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF or read online on Scribd
0% found this document useful (0 votes)
37 views

Multiple Myeloma

Uploaded by

Momo Semo
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF or read online on Scribd
You are on page 1/ 12
Multiple Myeloma Cancer B-cell development memory stem & CLL germinal Bce" . mature center @ cell a naive B-cell ; B-cell - f lymphoid e-: progenitor “EBs om um \ progenitor-B ae / tN pre-B DLBCL, ) rate FL, HL — cel B-cell Bone marrow Lymplietd tissue DLBCL (Diffuse large B cell lymphoma) FL (Follicular lymphoma) HL (Hodgkin lymphoma) What is Multiple Myeloma? An estimated 1420, 180 people diagnosed in the World in 2010 , . f blood cancer in which plasma cells grow aye itrollably, usually inside the bone marrow hat cause structural + Associated with bone lesions t i damage and/or fractures from overproduction of myeloma cells * Referred to as multiple myeloma because about 90% of patients have multiple bone lesions * Solitary plasmacytoma: a mass of myeloma cells in one site in the bone or another organ * Extramedullary plasmacytoma: myeloma that begins in other tissues, such as skin, muscle or lungs What is the Function of Plasma Cells? * Found inside the bone marrow * Part of the body’s immune system that produce antibodies to help the body fight infection y What are the Risk Factors for Multiple Myeloma? Age: Myeloma occurs most commonly in people over 60 years. The average age at diagnosis is 70 years. Only 2% of cases occur in people under 40 years. Race: Myeloma occurs twice as frequently in black people than in white people for unclear reasons. Exposure to radiation and chemicals History of solitary plasmacytoma Gender: more common in men Monoclonal gammopathy of unknown significance (MGUS, Paraproteinemia): is a condition in which an abnormal protein (monoclonal protein, paraprotein or M protein) is present in the blood at low level with no associated cause e.g. disease. What are the Symptoms of Multiple Myeloma? General Hypercalcemia ¢ Weight loss * Nausea and vomiting * Easy bruising * Increased urination * Hazy vision * Excessive thirst * Bleedinggums [| ‘ oN Bones s Pi ¢ Pain = & ¢ Fractures What are the Symptoms of Multiple Myeloma? cont... Kidney Failure Amyloidosis. (build-up of proteins) * Peripheral neuropathy (nerve damage) * Edema (swelling caused by build-up of fluid in the body) * Enlargement of organs + Nausea and vomiting ¢ Fatigue * Weakness What are the Symptoms of Multiple Myeloma? cont... Bone Marrow/Immune System Blood and Circulation * Anemia Disorders + Bleeding * Shortness of breath « Infections * Blood clots * Pneumonia * Bleeding How is Multiple Myeloma Diagnosed? + Blood test for anemia, kidney function, and calcium levels + Blood and urine tests to measure M protein levels * Diagnosis is confirmed with a bone marrow biopsy ° X-ray * Magnetic resonance imaging (MRI) * Computed tomography (CT or CAT) scan * Positron emission tomography (PET) scan or PET-CT Multiple Myeloma Staging * Durie-Salmon system (D-S) * The International Staging System (ISS) Durie-Salmon Staging System ‘N * Assesses the extent of the disease or size of the tumor * Divided into 3 stages + Each stage is classified into A or B depending on kidney function * Based on laboratory data including: — Red blood cell counts — Blood calcium levels — M protein levels — Amount of bone damage Durie-Salmon Staging System cont... * the symptoms related to the myeloma include hypercalcemia (elevated blood Calcium), poor Renal or kidney function, Anemia or Bone pain or bone lesions (CRAB). — Calcium levels increased: serum calcium > 0.25 mmol/L above the upper limit of normal or > 2.75 mmol/L — Renal insufficiency: creatinine > 173 mmol/L — Anemia: hemoglobin 2.g/dL below the lower limit of normal or hemoglobin < 10g/dL — Bone lesions; lytic lesions or osteoporosis (thinning of the bones) with compression fractures (an MRI or CT test may clarify) * Other: blood hyperviscosity, amyloidosis and/or recurren bacterial infections (more than 2 episodes in 12 months) y D-S Stage | Myeloma * Few cancer cells present in the body * May have no symptoms * Normal or slightly below normal red blood cell count * Normal calcium levels * Very low levels of M protein in the blood or urine * No bone damage on x-rays D-S Stage II Myeloma * More cancer cells are present in the body + Criteria for stage Il are defined as those that fit neither stage | nor stage Ill myeloma D-S Stage III Myeloma * Large number of cancer cells are present in the body * Anemia with a hemoglobin level less than 8.5 gm/dL Elevated blood calcium levels Advanced bone damage (more than three bone lesions) ° High levels of M protein in the blood or urine International Staging System (ISS) * Defines the factors that influence a person’s survival * Also divided into 3 stages * Based on laboratory data including: — Serum albumin — Serum betay-microglobulin (B2-M), a protein presents on all nucleated cells and plays a role in immunologic defense. B2-M may indicate a large number of myeloma cells are present and kidney damage has occurred. ISS , cont... + ISS Stage |: — B2-M levels are less than 3.5 gm/dL (grams per deciliter) — Blood albumin levels are greater than or equal to 3.5 gm/db * SS Stage Il: — Criteria for stage II are defined as those that fit neither stage | nor stage Ill myeloma « ISS Stage III: — B2-M level greater than 5.5gm/db How is Multiple Myeloma Treated? ¢ Treatment depends on many factors ¢ More than one treatment may be used * Active Surveillance (watchful wait): close observation without treatment for patients with no symptoms * Chemotherapy * Radiation therapy ¢ Surgery * Stem cell transplantation Cancer Treatment: Chemotherapy ‘N A combination of medications is often used i * Typical medications include cyclophosphamide (Cytoxan, Neosar), doxorubicin (Adriamycin), Doxorubicin liposome injection (Doxil), melphalan (Alkeran), vincristine (Oncovin), etoposide (Toposar, VePesid), cisplatin (Platinol), carmustine (BCNU) and dexamethasone (Decadron). Newer drugs include: thalidomide (Thalomid), lenalidomide (Revlimid), and bortezomib (Velcade; proteasome inhibitor) Side effects may include fatigue, risk of infection, nausea and vomiting, loss of appetite, and diarrhea Cancer Treatment: Radiation Therapy ¢ External beam: outside the body * May be used to control pain when chemotherapy is not effective * Not used to control bone pain due to structural damage + Side effects may include fatigue, mild skin reactions, upset stomach, and loose bowe\ movements Cancer Treatment: Surgery + Not used to treat myeloma * May be used to relieve pressure froma plasmacytoma * Kyphoplasty (Vertebroplasty): inflating and injecting bone cement into vertebrae to relieve pain, restore lost height and strengthen the spine Cancer Treatment: Stem Cell Transplantation/Bone Marrow Transplantation ¢ High-dose chemotherapy used to kill cancer cells « New stem cells are introduced from the patient (autologous) or a donor (allogeneic) to form new blood cells + Autologous stem cell transplantation is considered the standard treatment * Allogeneic stem cell transplantation is only recommended for patients with high-risk or recurrent myeloma Supportive Therapy for Myeloma ~ \ « Used to reduce symptoms and complications from myeloma * Treatment of anemia * Antibiotics and rarely intravenous immunoglobulins to treat and prevent infection * Bisphosphonate medications (drugs that increase bone density) to alleviate bone pain, reduce the risk of fractures and prevent hypercalcemia * Balanced diet high in calories, protein and healthy fluids * Exercise to maintain bone strength and reduce calcium loss After Treatment * Patients should talk with the physician about developing a follow-up care plan * Physician may recommend regular physical examinations, imaging tests and blood tests * Maintenance therapy for a year or longer to prevent recurrence * Intravenous bisphosphonates monthly * Fear of recurrence is common; patients should talk with your physician about ways to cope

You might also like